In the last trading session, 2.59 million Aquestive Therapeutics Inc (NASDAQ:AQST) shares changed hands as the company’s beta touched 2.75. With the company’s per share price at $2.80 changed hands at -$0.16 or -5.57% during last session, the market valuation stood at $254.85M. AQST’s last price was a discount, traded about -122.5% off its 52-week high of $6.23. The share price had its 52-week low at $2.24, which suggests the last value was 20.0% up since then.
Analysts gave the Aquestive Therapeutics Inc (AQST) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.11. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended AQST as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight.
Aquestive Therapeutics Inc (NASDAQ:AQST) trade information
Instantly AQST was in red as seen at the end of in last trading. With action -11.27%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -21.49%, with the 5-day performance at -11.27% in the red. However, in the 30-day time frame, Aquestive Therapeutics Inc (NASDAQ:AQST) is -9.55% down.
The consensus price target for the stock as assigned by Wall Street analysts is 10, meaning bulls need an upside of 72.0% from its current market value. According to analyst projections, AQST’s forecast low is 10 with 10 as the target high. To hit the forecast high, the stock’s price needs a -257.14% plunge from its current level, while the stock would need to soar -257.14% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 46.61%. The 2025 estimates are for Aquestive Therapeutics Inc earnings to decrease by -235.60%.
AQST Dividends
Aquestive Therapeutics Inc is expected to release its next quarterly earnings report in March.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 7.4099% or 5.45 million shares worth $14.18 million as of 2024-06-30.
Among Mutual Funds, the top two as of Sep 30, 2024 were Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF . With 2.4 shares estimated at $6.72 million under it, the former controlled 2.64% of total outstanding shares. On the other hand, iShares Russell 2000 ETF held about 2.28% of the shares, roughly 2.08 shares worth around $5.82 million.
